Ftse Mib
33.766,29
-0,06%
DAX
19.884,75
-0,57%
S&P 500
5.930,85
1,09%
NASDAQ
19.572,60
1,03%
Bitcoin
95.152,63
-2,11%
Pepperstone
Advertisement
Registration Strip Icon for alerts Registrati per avvisi in tempo reale, portafoglio personalizzato e movimenti di mercato.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Immunovant Inc (IMVT) Immunovant Inc (IMVT) Notizie

Immunovant Inc

IMVT
25,86
0,20 (0,78%)
21 Dic 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
18/12/202423:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/12/202423:01EDGAR2Form 3 - Initial statement of beneficial ownership of..
22/11/202422:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/11/202422:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/11/202422:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/11/202423:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/11/202423:11EDGAR2Form 3 - Initial statement of beneficial ownership of..
07/11/202412:49EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/11/202412:42EDGAR2Form 8-K - Current report
07/11/202412:30GLOBEImmunovant Provides Development Updates and Reports..
29/10/202411:30GLOBEImmunovant Announces Oral Presentation of Late Breaking..
25/10/202422:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/10/202422:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/10/202422:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/10/202422:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/10/202422:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/10/202422:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/9/202413:40EDGAR2Form 8-K - Current report
09/9/202413:00GLOBERoivant Provides Update on Graves’ Disease Development..
09/9/202409:55GLOBEImmunovant Provides Update on Graves’ Disease Development..
05/9/202412:30GLOBEImmunovant to Host Graves’ Disease Program Update on..
23/8/202422:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/8/202422:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/8/202422:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/8/202422:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/8/202422:12EDGAR2Form 8-K - Current report
06/8/202422:19EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
06/8/202422:13EDGAR2Form 8-K - Current report
06/8/202422:05GLOBEImmunovant Reports Financial Results and Provides Corporate..
26/7/202422:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/7/202423:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/7/202423:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/7/202423:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/7/202423:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/7/202423:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/7/202423:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/7/202423:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/5/202422:36EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
29/5/202422:17EDGAR2Form 8-K - Current report
29/5/202422:01GLOBEImmunovant Provides Corporate Updates and Reports Financial..
24/5/202422:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/5/202422:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/5/202422:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/5/202422:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/3/202412:30GLOBEImmunovant Awarded U.S. Patent for IMVT-1402
23/2/202422:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/2/202422:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/2/202422:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/2/202414:47EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
12/2/202413:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Apertura: 25,44 Min: 25,25 Max: 26,27
Chiusura: 25,66

La tua Cronologia

NASDAQ
IMVT
Immunovant
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network